Fangda Law Firm advised Shanghai Bao Pharmaceuticals Co., Ltd. and Suzhou Centergene Pharmaceuticals Co., Ltd. on the deal. Organon China, a healthcare company with a focus...
Organon China’s License and Supply Agreement with Shanghai Bao Pharmaceuticals
Sino-American Silicon Products’ $284 Million Shares Offering
Sullivan & Cromwell advised the initial purchaser, J.P. Morgan, on the offering. Sino-American Silicon Products Inc. (SAS) completed its offering of $284 million global depositary shares...
CStone Pharmaceuticals’ Collaboration Agreement with Ewopharma
Fangda acted as legal counsel to CStone in the transaction and provided comprehensive legal services. CStone has entered into a strategic commercial collaboration with the European...
Zhejiang Construction Investment Group Company’s $450 Million Acquisition of Nantong Jianghai
Sullivan & Cromwell represented Yeebo on the transaction. Yeebo (International Holdings) (Yeebo) announced that its subsidiary, Billion Power Investment, agreed to sell 20.02 percent equity interest...